Literature DB >> 19120351

Immunoglobulin isotypes in multiple myeloma: laboratory correlates and prognostic implications in total therapy protocols.

Bijay Nair, Sarah Waheed, Jackie Szymonifka, John D Shaughnessy, John Crowley, Bart Barlogie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19120351      PMCID： PMC3644943          DOI： 10.1111/j.1365-2141.2008.07547.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  9 in total

1.  The molecular classification of multiple myeloma.

Authors:  Fenghuang Zhan; Yongsheng Huang; Simona Colla; James P Stewart; Ichiro Hanamura; Sushil Gupta; Joshua Epstein; Shmuel Yaccoby; Jeffrey Sawyer; Bart Burington; Elias Anaissie; Klaus Hollmig; Mauricio Pineda-Roman; Guido Tricot; Frits van Rhee; Ronald Walker; Maurizio Zangari; John Crowley; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2006-05-25       Impact factor: 22.113

2.  Total therapy with tandem transplants for newly diagnosed multiple myeloma.

Authors:  B Barlogie; S Jagannath; K R Desikan; S Mattox; D Vesole; D Siegel; G Tricot; N Munshi; A Fassas; S Singhal; J Mehta; E Anaissie; D Dhodapkar; S Naucke; J Cromer; J Sawyer; J Epstein; D Spoon; D Ayers; B Cheson; J Crowley
Journal:  Blood       Date:  1999-01-01       Impact factor: 22.113

3.  International staging system for multiple myeloma.

Authors:  Philip R Greipp; Jesus San Miguel; Brian G M Durie; John J Crowley; Bart Barlogie; Joan Bladé; Mario Boccadoro; J Anthony Child; Herve Avet-Loiseau; Jean-Luc Harousseau; Robert A Kyle; Juan J Lahuerta; Heinz Ludwig; Gareth Morgan; Raymond Powles; Kazuyuki Shimizu; Chaim Shustik; Pieter Sonneveld; Patrizia Tosi; Ingemar Turesson; Jan Westin
Journal:  J Clin Oncol       Date:  2005-04-04       Impact factor: 44.544

4.  A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.

Authors:  John D Shaughnessy; Fenghuang Zhan; Bart E Burington; Yongsheng Huang; Simona Colla; Ichiro Hanamura; James P Stewart; Bob Kordsmeier; Christopher Randolph; David R Williams; Yan Xiao; Hongwei Xu; Joshua Epstein; Elias Anaissie; Somashekar G Krishna; Michele Cottler-Fox; Klaus Hollmig; Abid Mohiuddin; Mauricio Pineda-Roman; Guido Tricot; Frits van Rhee; Jeffrey Sawyer; Yazan Alsayed; Ronald Walker; Maurizio Zangari; John Crowley; Bart Barlogie
Journal:  Blood       Date:  2006-11-14       Impact factor: 22.113

5.  Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases.

Authors:  J Bladé; J A Lust; R A Kyle
Journal:  J Clin Oncol       Date:  1994-11       Impact factor: 44.544

6.  Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3.

Authors:  Bart Barlogie; Elias Anaissie; Frits van Rhee; Jeffrey Haessler; Klaus Hollmig; Mauricio Pineda-Roman; Michele Cottler-Fox; Abid Mohiuddin; Yazan Alsayed; Guido Tricot; Vanessa Bolejack; Maurizio Zangari; Joshua Epstein; Nathan Petty; Douglas Steward; Bonnie Jenkins; Jennifer Gurley; Ellen Sullivan; John Crowley; John D Shaughnessy
Journal:  Br J Haematol       Date:  2007-07       Impact factor: 6.998

7.  Thalidomide and hematopoietic-cell transplantation for multiple myeloma.

Authors:  Bart Barlogie; Guido Tricot; Elias Anaissie; John Shaughnessy; Erik Rasmussen; Frits van Rhee; Athanasios Fassas; Maurizio Zangari; Klaus Hollmig; Mauricio Pineda-Roman; Choon Lee; Giampaolo Talamo; Raymond Thertulien; Elias Kiwan; Somashekar Krishna; Michele Fox; John Crowley
Journal:  N Engl J Med       Date:  2006-03-09       Impact factor: 91.245

8.  Review of 1027 patients with newly diagnosed multiple myeloma.

Authors:  Robert A Kyle; Morie A Gertz; Thomas E Witzig; John A Lust; Martha Q Lacy; Angela Dispenzieri; Rafael Fonseca; S Vincent Rajkumar; Janice R Offord; Dirk R Larson; Matthew E Plevak; Terry M Therneau; Philip R Greipp
Journal:  Mayo Clin Proc       Date:  2003-01       Impact factor: 7.616

9.  Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients.

Authors:  M Krejci; T Buchler; R Hajek; A Svobodnik; A Krivanova; L Pour; Z Adam; J Mayer; J Vorlicek
Journal:  Bone Marrow Transplant       Date:  2005-01       Impact factor: 5.483
  9 in total
  10 in total

1.  Excess Free Light Chains in Serum Immunofixation Electrophoresis: Attributes of a Distinctive Pattern.

Authors:  Bharani Vani; Aggarwal Ritu; Sharma Praveen; Malhotra Pankaj; Ranjana Minz
Journal:  Indian J Hematol Blood Transfus       Date:  2018-01-31       Impact factor: 0.900

2.  Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study.

Authors:  Donna E Reece; David H Vesole; Smriti Shrestha; Mei-Jie Zhang; Waleska S Pérez; Angela Dispenzieri; Gustavo A Milone; Muneer Abidi; Harold Atkins; Asad Bashey; Christopher N Bredeson; Willem Bujan Boza; César O Freytes; Robert Peter Gale; James L Gajewski; John Gibson; Gregory A Hale; Shaji Kumar; Robert A Kyle; Hillard M Lazarus; Philip L McCarthy; Santiago Pavlovsky; Vivek Roy; Daniel J Weisdorf; Peter H Wiernik; Parameswaran N Hari
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2010-12

3.  Evaluation of Double M-Band on Serum Protein Electrophoresis Simulating Biclonal Gammopathy: A Case Report.

Authors:  Pallavi Jain; Reeta Choudhary; Arun Kumar Harith; Charu Yadav
Journal:  Indian J Clin Biochem       Date:  2021-04-08

4.  Real World Multiple Myeloma Registry from Jordan, a Developing Country.

Authors:  Farah Qasem; A'sem Abu-Qamar; Batool Aqel; Rand Aladayleh; Alteerah R Ilham; Ahmad Magableh; Hisham Bawa Neh; Feras Al-Fararjeh; Abdalla Awidi
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-05-01       Impact factor: 3.122

5.  Efficacy and outcome of autologous transplantation in rare myelomas.

Authors:  Curly Morris; Mary Drake; Jane Apperley; Simona Iacobelli; Anja van Biezen; Bo Bjorkstrand; Hartmut Goldschmidt; Jean-Luc Harousseau; Gareth Morgan; Theo de Witte; Dietger Niederwieser; Gosta Gahrton
Journal:  Haematologica       Date:  2010-10-22       Impact factor: 9.941

6.  Changes in renal function after different tandem hematopoietic stem-cell transplantation approaches in patients with multiple myeloma.

Authors:  Seok Hui Kang; Hyeon Seok Hwang; Hoon Suk Park; In O Sun; Sun Ryoung Choi; Byung Ha Chung; Bum Soon Choi; Chul Woo Yang; Yong Soo Kim; Chang Ki Min; Cheol Whee Park
Journal:  J Korean Med Sci       Date:  2011-10-01       Impact factor: 2.153

7.  Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2012.

Authors:  Vânia Tietsche de Moraes Hungria; Edvan de Queiroz Crusoe; Adriana Alvarez Quero; Manuella Sampaio; Angelo Maiolino; Wanderley Marques Bernardo
Journal:  Rev Bras Hematol Hemoter       Date:  2013

8.  Factors Explaining the Coincidence of Smoldering Multiple Myeloma and Primary Biliary Cholangitis: A Case Report.

Authors:  Mirna El Dirani; Julius M Nagaratnam; Samer Kholoki
Journal:  Cureus       Date:  2022-07-13

9.  Whole-genome optical mapping of bone-marrow myeloma cells reveals association of extramedullary multiple myeloma with chromosome 1 abnormalities.

Authors:  Eva Kriegova; Regina Fillerova; Jiri Minarik; Jakub Savara; Jirina Manakova; Anna Petrackova; Martin Dihel; Jana Balcarkova; Petra Krhovska; Tomas Pika; Petr Gajdos; Marek Behalek; Michal Vasinek; Tomas Papajik
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

10.  Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma Patients.

Authors:  Adrien Bosseboeuf; Célia Seillier; Nicolas Mennesson; Sophie Allain-Maillet; Maeva Fourny; Anne Tallet; Eric Piver; Philippe Lehours; Francis Mégraud; Laureline Berthelot; Jean Harb; Edith Bigot-Corbel; Sylvie Hermouet
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.